Digital Health Interventions for Integrated Management of Obesity, HTN, and DM in Patients with Early-Stage CKD: Impact on CV Risk Reduction

Chronic Kidney Disease (CKD) is an increasing health burden worldwide that has a close relationship with cardiometabolic diseases like obesity, hypertension, and diabetes, which together hasten the development of the disease and predispose the patient to cardiovascular diseases substantially. The growing number of these conditions, taken in combination, underscores the need to adopt integrated and scalable management strategies, especially in the early stages of CKD, when intervention is most likely to be successful. Epidemiological data emphasize that CKD is a disease in millions of people around the globe and has a close connection with the rise in morbidity and mortality caused by cardiovascular diseases (Bikbov et al., 2020; Webster et al., 2020). Meanwhile, innovation in digital health technologies has revealed new possibilities for managing chronic diseases through continuous monitoring, individualized care, and enhanced patient interaction. Telemedicine and mobile health (mHealth) tools and services, as a subset of Digital Health Interventions, have become essential in facilitating the coordinated management of obesity, hypertension, and diabetes in a networked care model. Such technologies enable real-time monitoring of important clinical parameters like blood glucose level, blood pressure, and body mass index, as well as behavior change and compliance with treatment regimens (Giansanti, 2021; Keesara et al., 2020). Healthcare systems can stop being fragmented in their care delivery by incorporating various risk factors into a unified digital ecosystem that would help transition to a more holistic approach to care delivery, which would be consistent with the notion of Cardiorenal-Metabolic Syndrome. Cardiovascular risk reduction hinges on early diagnosis, timely intervention, and effective long-term disease management to alleviate poor outcomes. This article summarizes evidence on digital health-enabled integrated care for patients with early-stage CKD, emphasizing its relevance for optimal clinical outcomes. It advances the field by presenting a holistic model that integrates technological innovation with cardiometabolic disease control, offering perspectives on the future of scalable and patient-centered healthcare delivery (Chen et al., 2021; Joseph et al., 2022).